Resultados da pesquisa - Jérôme Rey

  • A mostrar 1 - 16 resultados de 16
Refinar resultados
  1. 1
    Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases

    Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases Por Benoît Bareau, Jérôme Rey, M. Hamidou, Jean Donadieu, Jeff Morçet, Oumédaly Reman, N. Schleinitz, Olivier Tournilhac, Mikaël Roussel, Thierry Fest, T. Lamy

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  2. 2
    Kinetics of Cytotoxic Lymphocytes Reconstitution after Induction Chemotherapy in Elderly AML Patients Reveals Progressive Recovery of Normal Phenotypic and Functional Features in NK Cells

    Kinetics of Cytotoxic Lymphocytes Reconstitution after Induction Chemotherapy in Elderly AML Patients Reveals Progressive Recovery of Normal Phenotypic and Functional Features in N... Por Jérôme Rey, Cyril Fauriat, Eloïse Kochbati, Florence Orlanducci, Aude Charbonnier, Evelyne D’Incan, Pascale André, François Romagné, Bernadette Barbarat, Norbert Vey, Daniel Olive

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  3. 3
    Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasms

    Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasms Por Geoffroy Venton, Frédéric Courtier, Aude Charbonnier, Evelyne D’Incan, Colombe Saillard, Bilal Mohty, Julien Mozziconacci, Daniel Birnbaum, Anne Murati, Norbert Vey, Jérôme Rey

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    Genomic analysis of myeloproliferative neoplasms in chronic and acute phases

    Genomic analysis of myeloproliferative neoplasms in chronic and acute phases Por Frédéric Courtier, Nadine Carbuccia, Séverine Garnier, Arnaud Guillé, José Adélaı̈de, Nathalie Cervera, Véronique Gelsi‐Boyer, Julien Mozziconacci, Jérôme Rey, Norbert Vey, Max Chaffanet, Daniel Birnbaum, Anne Murati

    Publicado em 2016
    Obter o texto integral
    Carta
    Adic. favoritos
    Na minha lista:
  5. 5
    A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies

    A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies Por Norbert Vey, Lionel Karlin, Sophie Sadot‐Lebouvier, Florence Broussais, Dominique Berton-Rigaud, Jérôme Rey, Aude Charbonnier, Delphine Marie, Pascale André, Carine Paturel, Robert Zerbib, Jaafar Bennouna, Gilles Salles, Anthony Gonçalvès

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo

    Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo Por Emmanuelle Verger, Juliette Soret‐Dulphy, Nabih Maslah, Lydia Roy, Jérôme Rey, Zineb Ghrieb, Róbert Královics, Heinz Gisslinger, Barbara Grohmann-Izay, Christoph Klade, Christine Chomienne, Stéphane Giraudier, Bruno Cassinat, Jean‐Jacques Kiladjian

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients

    Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients Por Sylvain Garciaz, Marie‐Anne Hospital, Anne‐Sophie Alary, Colombe Saillard, Yosr Hicheri, Bilal Mohty, Jérôme Rey, Evelyne D’Incan, Aude Charbonnier, Ferdinand Villetard, Valério Maisano, Laura Lombardi, Antoine Ittel, Julien Mozziconacci, Véronique Gelsi‐Boyer, Norbert Vey

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML

    NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML Por Anne-Sophie Chrétien, Raynier Devillier, Cyril Fauriat, Florence Orlanducci, Samia Harbi, Aude Le Roy, Jérôme Rey, Gaelle Bouvier Borg, Emmanuel Gautherot, Jean-François Hamel, Norbert Ifrah, Catherine Lacombe, Pascale Cornillet‐Lefèbvre, Jacques Delaunay, Antoine Toubert, Christine Arnoulet, Norbert Vey, Didier Blaise, Daniel Olive

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison

    HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leuke... Por Raynier Devillier, Faézeh Legrand, Jérôme Rey, Luca Castagna, Sabine Fürst, Angéla Granata, Aude Charbonnier, Samia Harbi, Evelyne D’Incan, Thomas Pagliardini, Catherine Faucher, Claude Lemarié, Colombe Saillard, Boris Calmels, Bilal Mohty, Valério Maisano, Pierre‐Jean Weiller, Christian Chabannon, Norbert Vey, Didier Blaise

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  10. 10
    NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia

    NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia Por Anne-Sophie Chrétien, Cyril Fauriat, Florence Orlanducci, Jérôme Rey, Gaelle Bouvier Borg, Emmanuel Gautherot, Samuel Granjeaud, Clémence Demerle, Jean-François Hamel, Adelheid Cerwenka, Elke Pogge von Strandmann, Norbert Ifrah, Catherine Lacombe, Pascale Cornillet‐Lefèbvre, Jacques Delaunay, Antoine Toubert, Christine Arnoulet, Norbert Vey, Daniel Olive

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    Efficacy and safety of pegylated‐interferon α‐2a in myelofibrosis: a study by the <scp>FIM</scp> and <scp>GEM</scp> French cooperative groups

    Efficacy and safety of pegylated‐interferon α‐2a in myelofibrosis: a study by the <scp>FIM</scp> and <scp>GEM</scp> French cooperative groups Por Jean‐Christophe Ianotto, Françoise Boyer‐Perrard, Emmanuel Gyan, Kamel Laribi, Pascale Cony‐Makhoul, Jean‐Loup Demory, Benoît de Renzis, Christine Dosquet, Jérôme Rey, Lydia Roy, Brigitte Dupriez, Laurent Knoops, Laurence Legros, Mohamed Malou, P. Hutin, Dana Ranta, M. Schoenwald, Annalisa Andreoli, Jean‐François Abgrall, Jean‐Jacques Kiladjian

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  12. 12
    Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms (FIM) study

    Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms... Por Jean‐Christophe Ianotto, Aurélie Chauveau, Françoise Boyer‐Perrard, Emmanuel Gyan, Kamel Laribi, Pascale Cony‐Makhoul, Jean‐Loup Demory, Benoît de Renzis, Christine Dosquet, Jérôme Rey, Lydia Roy, Brigitte Dupriez, Laurent Knoops, Laurence Legros, Mohamed Malou, P. Hutin, Dana Ranta, Omar Benbrahim, Valérie Ugo, Éric Lippert, Jean‐Jacques Kiladjian

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia

    Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia Por Anne-Sophie Chrétien, Cyril Fauriat, Florence Orlanducci, Claire Galseran, Jérôme Rey, Gaelle Bouvier Borg, Emmanuel Gautherot, Samuel Granjeaud, Jean‐François Hamel‐Broza, Clémence Demerle, Norbert Ifrah, Catherine Lacombe, Pascale Cornillet‐Lefèbvre, Jacques Delaunay, Antoine Toubert, Emilie Gregori, Hervé Luche, Marie Malissen, Christine Arnoulet, Jacques A. Nunès, Norbert Vey, Daniel Olive

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  14. 14
    Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients

    Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients Por Florent Malard, Anne Vekhoff, Simona Lapusan, Françoise Isnard, Evelyne D’incan-Corda, Jérôme Rey, Colombe Saillard, Xavier Thomas, Sophie Ducastelle-Leprêtre, Étienne Paubelle, Marie‐Virginie Larcher, Clément Rocher, Christian Récher, Suzanne Tavitian, Sarah Bertoli, Anne‐Sophie Michallet, Lila Gilis, Pierre Péterlin, Patrice Chevallier, Stéphanie Nguyen, Émilie Plantamura, Lilia Boucinha, Cyrielle Gasc, Mauricette Michallet, Joël Doré, Ollivier Legrand, Mohamad Mohty

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  15. 15
    Epidemiology, clinical picture and long‐term outcomes of<i>FIP1L1‐PDGFRA</i>‐positive myeloid neoplasm with eosinophilia: Data from 151 patients

    Epidemiology, clinical picture and long‐term outcomes of<i>FIP1L1‐PDGFRA</i>‐positive myeloid neoplasm with eosinophilia: Data from 151 patients Por Julien Rohmer, Amélie Couteau‐Chardon, Julie Trichereau, Kewin Panel, Cyrielle Gesquiere, Raouf Ben Abdelali, Audrey Bidet, Jean‐Sébastien Blade, Jean‐Michel Cayuela, Pascale Cony‐Makhoul, Vincent Cottin, Éric Delabesse, Mikaël Ebbo, O. Fain, Pascale Flandrin‐Gresta, Lionel Galicier, Catherine Godon, Nathalie Grardel, Aurélien Guffroy, M. Hamidou, Mathilde Hunault, Nicolas Etienne, Faustine Lhomme, Ludovic Lhermitte, Irène Machelart, Laurent Mauvieux, Catherine Mohr, Marie‐Joelle Mozicconacci, Dina Naguib, Franck E. Nicolini, Jérôme Rey, Philippe Rousselot, Suzanne Tavitian, Louis Terriou, Guillaume Lefèvre, Claude Preudhomme, Jean‐Emmanuel Kahn, Matthieu Groh

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  16. 16
    Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of <i>ASXL1</i> mutations: a FIM study

    Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of <i>ASXL1</i> mutations: a FIM study Por Damien Luque Paz, Jérémie Riou, Emmanuelle Verger, Bruno Cassinat, Aurélie Chauveau, Jean‐Christophe Ianotto, Brigitte Dupriez, Françoise Boyer, Maxime Renard, Olivier Mansier, Anne Murati, Jérôme Rey, Gabriel Étienne, Véronique Mansat‐De Mas, Suzanne Tavitian, Olivier Nibourel, Stéphane Girault, Yannick Le Bris, François Girodon, Dana Ranta, Jean‐Claude Chomel, Pascale Cony‐Makhoul, Pierre Sujobert, Margot Robles, Raouf Ben Abdelali, Olivier Kosmider, Laurane Cottin, Lydia Roy, Ivan Sloma, Fabienne Vacheret, Mathieu Wémeau, Pascal Mossuz, Borhane Slama, Vincent Cussac, Guillaume Denis, Anouk Walter-Petrich, Barbara Burroni, Nathalie Jézéquel, Stéphane Giraudier, Éric Lippert, Gerard Socié, Jean‐Jacques Kiladjian, Valérie Ugo

    Publicado em 2021
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: